#Pharmaceuticals

INK Videos Oct 28, 2021
INK Ultra Money Free: BioVaxys insiders bet on the haptenization of cancer and covid
During the last week of October we put the Healthcare sector in the spotlight. On Wednesday, we ventured into the biotech space where BioVaxys (BIOV) insiders are betting big on their firm's novel approach to tackling cancer and COVID-19. Join us as a Canadian Insider or INK Research member as we let the insiders guide us to opportunity this fall.
INK Videos Oct 27, 2021
BioVaxys insiders bet on the haptenization of cancer and covid
We are continuing with our mini-series on Healthcare stocks by venturing into the biotech space. BioVaxys insiders are betting big on their firm's novel approach to tackling cancer and COVID-19.
INK Videos Apr 22, 2022
FSD Pharma swims against the bearish tide INK preview 22 April 2022
Today, we return to one of the few stocks in the alternative medicine area that have held their own during 2022. It has been a rocky ride for FSD Pharma (HUGE), but so far it is flat year-to-date compared to steep declines for many of its peers.